You have no items in your shopping cart.
IL2 Antibody
Description
Images & Validation
−| Tested Applications | ELISA |
|---|---|
| Reactivity | Virus |
| Application Notes |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Rabbit |
| Clonality | Recombinant |
| Isotype | Rabbit IgG |
| Clone No. | 1Q8G7 |
| Immunogen | Recombinant Human IL2 Protein, amino acids Ala21-Thr153 |
| Target | IL2 |
| Purification | Affinity Purified, Endotoxin Level: < 1.0 EU/ug of the protein by LAL method. |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Buffer/Preservatives | Liquid |
| Concentration | 1mg/ml |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−ZEB1/NIL2A Rabbit Polyclonal Antibody [orb6954]
FC, IF, IHC-Fr, IHC-P, WB
Bovine, Canine, Gallus, Porcine, Rabbit
Human, Mouse, Rat
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl, 200 μlAnti-IL-2R alpha (CD25) [Basiliximab] [orb1152522]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mgAnti-IL-2R alpha (CD25) [Basiliximab] [orb348865]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mgAnti-IL-2R alpha (CD25) [Basiliximab] [orb348908]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.

From the comparison of the standard curve, it is found that ProSci has high sensitivity.

No significant cross-reactivity or interference was observed.

Placed at 37˚ for 3 days, the stability of the standard curve all conform to CV < 10%.
Quick Database Links
UniProt Details
−Documents Download
Request a Document
IL2 Antibody (orb1274380)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review







![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_6.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_6.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_6.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_1.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_2.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_3.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_4.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_5.png)